{"disease":{"id":"gynaecological-malignancies","name":"gynaecological malignancies"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05896020","title":"A Study of SHR-A1811 in Subjects With Gynaecologic Oncology","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":225,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT07210164","title":"Pre-habilitation Within ERAS Protocol for Gynecologic Oncology Surgery: The Pre_ERAS Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Aristotle University Of Thessaloniki","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}